Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base

Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base

After a century of controversies on its usefulness in protection against TB, underlying mechanisms of action, and benefits in various groups and geographical areas, the BCG vaccine is yet again a focus of global attention- this time due to the global COVID-19 pandemic caused by the novel severe acut...

Full description

Bibliographic Details
Main Authors: Jean B. Nachega, Markus Maeurer, Nadia A. Sam-Agudu, Jeremiah Chakaya, Patrick D.M. Katoto, Alimuddin Zumla
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:International Journal of Infectious Diseases
Subjects:
SARS-CoV-2
Tuberculosis
BCG
Immunity
COVID-19
Protection
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221002794

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221002794

Similar Items